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A Wolf in Sheep’s Clothing?*Gregory M. Marcus, MD, MAS,y Thomas A. Dewland, MDzP remature atrial contractions (PACs) have longbeen considered a benign electrophysiologicalphenomenon unlikely to result in serious clin-
ical consequence. In 1998, Haïssaguerre et al. (1) chal-
lenged this notion by demonstrating that targeted
ablation of ectopic atrial activity among patients
with atrial ﬁbrillation (AF) reduced arrhythmia recur-
rence. This ﬁnding strongly implicated PACs as the
acute trigger for AF initiation among patients previ-
ously diagnosed with the arrhythmia. Subsequent
studies among patients without known AF identiﬁed
an association between PACs and incident AF, both
in cohorts of patients with recent cryptogenic stroke
(2–4) and in the general population (5–7). It is notable
that in most of these studies, atrial ectopy emerged
as one of the strongest identiﬁable predictors of
incident AF. Indeed, our group (5) recently reported
that PAC count alone yields superior AF risk discrim-
ination and enhanced risk reclassiﬁcation when
compared with a previously validated multivariable
clinical AF risk model. Taken together, these earlier
studies identify atrial ectopy as an important AF
risk factor that may play a critical role in disease
pathogenesis.
Beyond enhancing our mechanistic construct of AF
initiation and perpetuation, the growing body of evi-
dence linking PACs to clinical disease suggests that*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
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travel reimbursement from Medtronic.atrial ectopy may represent a valuable clinical mea-
surement that could change treatment paradigms.
If the relationship between PACs and AF is causal,
for instance, treatment of atrial ectopy with either
pharmacological or catheter-based therapies could
provide a primary prevention strategy to reduce inci-
dent arrhythmia. Furthermore, it remains possible
that patients with multiple stroke risk factors may
beneﬁt from anticoagulation in the setting of a high
PAC burden to reduce the likelihood of stroke sec-
ondary to impending AF. These strategies remain
untested, however, and further data are necessary to
build support for clinical trials designed to evaluate
these novel therapeutic approaches.
In 2010, Binici et al. (6) used 48-hour ambulatory
monitoring data from the Copenhagen Holter Study
to assess the association between PACs and the
outcomes of incident AF, stroke, and death. In this
earlier investigation, excessive atrial ectopy was
deﬁned as either 30 or more PACs per hour or an
episode of 20 or more consecutive PACs (these deﬁ-
nitions were derived from the upper decile cutpoints
from the overall cohort). Importantly, over a median
follow-up of 6.3 years, this study found that excessive
atrial ectopy conferred a nearly 3-fold increased
risk of AF hospitalization. These investigators also
demonstrated that a high PAC burden was associated
with a combined endpoint of stroke or death, a
ﬁnding that persisted in a sensitivity analysis that
censored patients at the time of an AF diagnosis. This
last observation hinted at the intriguing notion that
PACs could be associated with adverse clinical
outcomes independent of AF.SEE PAGE 232In this issue of the Journal, Larsen et al. (8) take a
second look at the Copenhagen Holter Study data to
understand the relationship between atrial ectopy
and stroke more clearly. The duration of follow-up
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243has lengthened (median follow-up is now 14.4 years)
and is accompanied by an increase in clinical
events, including stroke diagnoses. Using deﬁnitions
and methodology similar to those of the previous
investigation, excessive atrial ectopy was associated
with a doubling in the adjusted risk of stroke (hazard
ratio: 2.02; 95% conﬁdence interval: 1.17 to 3.49).
Notably, only a minority of the patients with excessive
ectopy and stroke (14.3%) had a clinical diagnosis of
AF before their cerebrovascular accident. Further-
more, the association between PACs and stroke per-
sisted in sensitivity analyses that censored patients
at the time of AF diagnosis or treated AF as a
time-varying exposure.
The present investigation has several strengths
that should be emphasized. Holter data were ob-
tained in an ambulatory, population-based cohort of
participants who were well characterized at baseline.
The investigators carefully considered and accounted
for potential confounders in their analysis, and they
applied appropriate statistical methodology to sub-
stantiate their ﬁndings. Participants were followed
for nearly 15 years, and, impressively, no patients
were lost to follow-up. In addition, the primary stroke
outcome used a speciﬁc deﬁnition that included
only ischemic events and required computed tomog-
raphy or magnetic resonance imaging for diagnostic
conﬁrmation.
We must also consider limitations that may affect
our interpretation of the results. As in all obser-
vational studies, residual confounding caused by
unmeasured or incompletely characterized covariates
could potentially result in bias. In addition, the con-
clusions of the present study may be less applicable
to U.S. patients, who may suffer medical comorbid-
ities at a frequency or severity different from that of
their Danish counterparts. As acknowledged by the
investigators, the present ﬁndings do not establish
causality, nor do they deﬁnitively implicate atrial
ectopy as the primary driver of increased risk of
stroke or death. The identiﬁcation of asymptomatic or
paroxysmal AF is difﬁcult and is an important limita-
tion shared by nearly all clinical AF investigations. As
such, we cannot exclude that some patients with
frequent PACs also had AF before theywere enrolled in
the study, nor can we be completely assured that pa-
tients who experienced stroke or death did not have
intervening AF. Finally, the investigators analyzed
the variability in atrial ectopy between the ﬁrst and
second 24-h periods of Holter monitoring to argue that
this monitoring technique has excellent day-to-day
reproducibility in detecting a high ectopic atrial
burden. The reproducibility and predictive character-
istics of serial ambulatory electrocardiographicmonitoring at greater time intervals are less clear,
however, and the current results do not inform
decisions regarding the utility of repeat monitoring
for reassessment of clinical risk.
How then do we interpret these results in the
context of the earlier literature? Perhaps the most
logical explanation, appropriately mentioned by
Larsen et al. (8), is that patients with a high burden of
atrial ectopy are more likely to develop subclinical
AF, which subsequently leads to stroke. As discussed
earlier, the limitations in AF diagnosis make this a
strong possibility. Further attempts to clarify this
issue would be valuable because it is possible that
PAC treatment could prevent AF and subsequent
strokes without the attendant risks and costs of
anticoagulation therapy. A more controversial expla-
nation of the present study is that frequent ectopy
results in atrial myopathy that drives both AF and
stroke risk. According to what we call the “atrial
myopathy hypothesis,” AF would be an epiphenom-
enon outside the causal pathway between PACs and
stroke. In considering this possibility, it is impor-
tant to remember that both TRENDS and ASSERT
(Asymptomatic Atrial Fibrillation and Stroke Evalua-
tion in Pacemaker Patients and the Atrial Fibrillation
Reduction Atrial Pacing Trial) trials (9,10) showed no
clear temporal association between AF and stroke
outcomes as assessed using implantable cardiac de-
vice monitoring. In fact, some study participants had
device-documented AF only after their cerebrovascu-
lar event. In light of the current investigation, it re-
mains possible that the stroke outcomes observed
among these device-monitored patients could be
explained by the atrial myopathy hypothesis. Finally,
it is important to consider that an unidentiﬁed primary
process may serve to increase atrial ectopy, AF,
and stroke risk through separate mechanisms. For
instance, as recognized by the investigators, sleep
apnea or left atrial enlargement, or both, could result in
heightened atrial ectopy and could also increase stroke
risk through an alternative pathological pathway. Such
a phenomenon would be important to recognize
because treatment of PACs in this situation would not
be expected to reduce either AF or stroke outcomes.
Because atrial ectopy is strongly correlated with other
stroke and AF risk factors, a clinical trial that ran-
domizes patients with frequent ectopy to various PAC
reduction treatments offers the best hope of under-
standing these potentially complex relationships.
Regardless of which of the foregoing explanations is
ultimately proven correct, it remains evident that
atrial ectopy has an important role in stroke predic-
tion. In this context, it is also worthwhile to consider
the absolute risk associated with a high PAC burden.
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244Among participants in this study with a very high
burden of atrial ectopic activity relative to the
remainder of the population (the top decile of total or
consecutive PAC counts), the risk of stroke was
approximately 1 in 5. Although this group certainly
represents a high-risk cohort, the majority of partici-
pants in the excess ectopy group did not develop the
study outcome over the long duration of follow-up.
Mounting evidence continues to implicate the role
of PACs in the development of clinical diseases
such as atrial ﬁbrillation and stroke, and the hope is
that continued research efforts will more clearly
delineate the causal pathways responsible for thisassociation. The ﬁnding of frequent PACs on ambu-
latory monitoring should no longer be viewed as a
benign and easily dismissible observation. Although
the appropriate course of action remains unclear, a
high burden of atrial ectopy should raise an eyebrow
and heighten clinical concern.
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